What's new

Pharmacovigilance Risk Assessment Committee (PRAC): 2 - 5 June 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 June 2025 to 5 June 2025

Pharmacovigilance Risk Assessment Committee (PRAC): 2 - 5 June 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 June 2025 to 5 June 2025

Jun 2, 2025 - 17:40
 0
Pharmacovigilance Risk Assessment Committee (PRAC): 2 - 5 June 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 June 2025 to 5 June 2025
Pharmacovigilance Risk Assessment Committee (PRAC): 2 - 5 June 2025, European Medicines Agency, Amsterdam, the Netherlands, from 2 June 2025 to 5 June 2025
Read More

Tags:

Previous Article

STAT+: What to know about the man who led DOGE’s cost cuts at HHS

Next Article

Faecal microbiota transplantation EU-IN Horizon Scanning Report

Related Posts

European shortages monitoring platform (ESMP): updates and question and answer (Q&A) clinic for marketing authorisation holders (MAHs), Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 June 2025, 10:30 (CEST) to 24 June 2025, 12:00 (CEST)

European shortages monitoring platform (ESMP): updates ...

May 14, 2025  0

EMA workshop on primary efficacy endpoints for antivirals and monoclonal antibodies intended for the treatment of COVID-19 and influenza, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 June 2025, 13:00 (CEST) to 6 June 2025, 17:00 (CEST)

EMA workshop on primary efficacy endpoints for antivira...

May 13, 2025  0

Human medicines European public assessment report (EPAR): Uzpruvo, ustekinumab, Date of authorisation: 05/01/2024, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0